| Year |
Citation |
Score |
| 2023 |
Mani C, Acharya G, Saamarthy K, Ochola D, Mereddy S, Pruitt K, Manne U, Palle K. Racial differences in RAD51 expression are regulated by miRNA-214-5P and its inhibition synergizes with olaparib in triple-negative breast cancer. Breast Cancer Research : Bcr. 25: 44. PMID 37081516 DOI: 10.1186/s13058-023-01615-6 |
0.327 |
|
| 2023 |
Agarwal S, Afaq F, Bajpai P, Behring M, Kim HG, Varambally A, Chandrashekar DS, Peter S, Diffalha SA, Khushman M, Seeber A, Varambally S, Manne U. BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis. Molecular Cancer Research : McR. OF1-OF15. PMID 37067340 DOI: 10.1158/1541-7786.MCR-23-0003 |
0.34 |
|
| 2021 |
Espinoza I, Agarwal S, Sakiyama M, Shenoy V, Orr WS, Diffalha SA, Prizment A, Varambally S, Manne U, Gomez CR. Expression of MHC class I polypeptide-related sequence A (MICA) in colorectal cancer. Frontiers in Bioscience (Landmark Edition). 26: 765-776. PMID 34719204 DOI: 10.52586/4986 |
0.336 |
|
| 2020 |
Espinoza I, Agarwal S, Reddy A, Shenoy V, Subramony C, Sakiyama M, Fair L, Poosarla T, Zhou X, Shannon Orr W, Lahr C, Bae S, Al Diffalha S, Manne U, Gomez CR. Expression of trefoil factor 3 is decreased in colorectal cancer. Oncology Reports. PMID 33210724 DOI: 10.3892/or.2020.7829 |
0.322 |
|
| 2020 |
Agarwal S, Behring M, Kim HG, Chandrashekar DS, Chakravarthi BVSK, Gupta N, Bajpai P, Elkholy A, Al Diffalha S, Datta PK, Heslin MJ, Varambally S, Manne U. TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status. Molecular Oncology. PMID 33037736 DOI: 10.1002/1878-0261.12821 |
0.343 |
|
| 2020 |
Agarwal S, Chakravarthi BVSK, Kim HG, Gupta N, Hale K, Balasubramanya SAH, Oliver PG, Thomas DG, Eltoum IA, Buchsbaum DJ, Manne U, Varambally S. PAICS, a De Novo Purine Biosynthetic Enzyme, Is Overexpressed in Pancreatic Cancer and Is Involved in Its Progression. Translational Oncology. 13: 100776. PMID 32422575 DOI: 10.1016/J.Tranon.2020.100776 |
0.396 |
|
| 2020 |
Davis M, Martini R, Newman L, Elemento O, White J, Verma A, Datta I, Adrianto I, Chen Y, Gardner K, Kim HG, Colomb WD, Eltoum IE, Frost AR, Grizzle WE, ... ... Manne U, et al. Identification of Distinct Heterogenic Subtypes and Molecular Signatures Associated with African Ancestry in Triple Negative Breast Cancer Using Quantified Genetic Ancestry Models in Admixed Race Populations. Cancers. 12. PMID 32414099 DOI: 10.3390/Cancers12051220 |
0.356 |
|
| 2020 |
Chandrashekar DS, Chakravarthi BVSK, Robinson AD, Anderson JC, Agarwal S, Balasubramanya SAH, Eich ML, Bajpai AK, Davuluri S, Guru MS, Guru AS, Naik G, Della Manna DL, Acharya KK, Carskadon S, ... Manne U, et al. Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression. Oncogene. PMID 32231273 DOI: 10.1038/S41388-020-1275-7 |
0.378 |
|
| 2020 |
Agarwal S, Chakravarthi BVSK, Behring M, Kim HG, Chandrashekar DS, Gupta N, Bajpai P, Elkholy A, Balasubramanya SAH, Hardy C, Diffalha SA, Varambally S, Manne U. PAICS, a Purine Nucleotide Metabolic Enzyme, is Involved in Tumor Growth and the Metastasis of Colorectal Cancer. Cancers. 12. PMID 32218208 DOI: 10.3390/Cancers12040772 |
0.455 |
|
| 2020 |
Agarwal S, Behring M, Kim HG, Bajpai P, Chakravarthi BVSK, Gupta N, Elkholy A, Al Diffalha S, Varambally S, Manne U. Targeting P4HA1 with a Small Molecule Inhibitor in a Colorectal Cancer PDX Model. Translational Oncology. 13: 100754. PMID 32199274 DOI: 10.1016/J.Tranon.2020.100754 |
0.441 |
|
| 2020 |
Manne A, Behring M, Manne U, Jacob R, Paluri RK. Hepatic and hematological toxicity associated with selective internal radiation therapy (SIRT): A meta-analysis of randomized clinical trials. Journal of Clinical Oncology. 38: 546-546. DOI: 10.1200/Jco.2020.38.4_Suppl.546 |
0.301 |
|
| 2020 |
Dean-Colomb WM, Martini R, Verma A, White J, Elemento O, Davis M, Newman L, Manne U, Yates C. Ancestry-specific gene expression profiles in TNBC tumors. Journal of Clinical Oncology. 38: 1547-1547. DOI: 10.1200/Jco.2020.38.15_Suppl.1547 |
0.371 |
|
| 2020 |
Bajpai P, Elholy A, Behring M, Chen D, Hale K, Agrawal S, Kim H, Jadhav T, Samuel T, Manne U. Abstract C044: Inter-ethnic differential gene expression in stage II recurrent colorectal cancers Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-C044 |
0.377 |
|
| 2020 |
Bhattarai S, Klimov S, Mittal K, Krishnamurthi U, Li XB, Wali D, Wetherilt CS, Riaz A, Aleskandarany MA, Green AR, Ellis IO, Gupta M, McCullough LE, Manne U, Agboola J, et al. Abstract PR18: Prognostic role of androgen receptor in triple-negative breast cancer: A global multi-institutional experience Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-Pr18 |
0.307 |
|
| 2020 |
Bhattarai S, Garlapati C, Arora K, Mittal K, Klimov S, Krishnamurti U, Li XB, Wali D, Gupta M, Manne U, Kapoor S, Cavalli L, Aneja R. Abstract P3-05-02: Upregulation of canonical Wnt signaling may underlie an aggressive disease course in androgen receptor-negative triple negative breast cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P3-05-02 |
0.311 |
|
| 2020 |
Bajpai P, Elkholy A, Agarwal S, Kim HG, Behring M, Manne U. Abstract 63: Navitoclax (ABT-263) induces apoptosis in colon cancer cells by upregulating caspase 3 through inhibition of Bcl-2 family members Cancer Research. 80: 63-63. DOI: 10.1158/1538-7445.Am2020-63 |
0.323 |
|
| 2020 |
Elkholy A, Behring M, Mohsen M, Bajpai P, Embaby A, Header D, Elwafa RA, Saeed H, Fouad M, Arafat W, Manne U. Abstract 6103: Absence of Mitsuokella multacida is associated with early onset of colorectal cancer Cancer Research. 80: 6103-6103. DOI: 10.1158/1538-7445.Am2020-6103 |
0.396 |
|
| 2019 |
Paluri R, Kasi A, Mcginnis T, Smith C, Williams G, Jacob R, Manne U, Gbolahan O, Naik G. Efficacy and tolerability of the combination of Liposomal irinotecan and 5-fluorouracil/leucovorin in advanced pancreatic cancers: post-approval clinic experience. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 30: iv74. PMID 32085281 DOI: 10.1093/Annonc/Mdz155.270 |
0.324 |
|
| 2019 |
Paluri R, Manne U, Williams G, Rose B, Heslin M, Reddy S, Kyanam Kabir Baig K, Vickers S, Ali A, Gbolahan O, Smith C, Jacob R. Neoadjuvant modified FOLFIRINOX or gemcitabine-nab paclitaxel followed by stereotactic body radiotherapy for patients with locally advanced pancreatic cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 30: iv67. PMID 32085253 DOI: 10.1093/Annonc/Mdz155.244 |
0.338 |
|
| 2019 |
Behring M, Hale K, Ozaydin B, Grizzle WE, Sodeke SO, Manne U. Inclusiveness and ethical considerations for observational, translational, and clinical cancer health disparity research. Cancer. PMID 31502259 DOI: 10.1002/Cncr.32495 |
0.341 |
|
| 2019 |
Agarwal S, Behring M, Hale K, Al Diffalha S, Wang K, Manne U, Varambally S. MTHFD1L, A Folate Cycle Enzyme, Is Involved in Progression of Colorectal Cancer. Translational Oncology. 12: 1461-1467. PMID 31421459 DOI: 10.1016/J.Tranon.2019.07.011 |
0.415 |
|
| 2019 |
Bhattarai S, Klimov S, Mittal K, Krishnamurti U, Li XB, Oprea-Ilies G, Wetherilt CS, Riaz A, Aleskandarany MA, Green AR, Ellis IO, Cantuaria G, Gupta M, Manne U, Agboola J, et al. Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study. Cancers. 11. PMID 31319547 DOI: 10.3390/Cancers11070995 |
0.325 |
|
| 2019 |
Hasan S, Jacob R, Manne U, Paluri R. Advances in pancreatic cancer biomarkers. Oncology Reviews. 13: 410. PMID 31044028 DOI: 10.4081/Oncol.2019.410 |
0.383 |
|
| 2019 |
Bedi D, Henderson HJ, Manne U, Samuel T. Camptothecin Induces PD-L1 and Immunomodulatory Cytokines in Colon Cancer Cells. Medicines (Basel, Switzerland). 6. PMID 31022845 DOI: 10.3390/Medicines6020051 |
0.385 |
|
| 2019 |
Hebert-Magee S, Yu H, Behring M, Jadhav T, Shanmugam C, Frost A, Eltoum IE, Varambally S, Manne U. The combined survival effect of codon 72 polymorphisms and p53 somatic mutations in breast cancer depends on race and molecular subtype. Plos One. 14: e0211734. PMID 30730944 DOI: 10.1371/Journal.Pone.0211734 |
0.352 |
|
| 2019 |
Katkoori VR, Anderson Z, Manne U, Bumpers H. Abstract 3879: Inhibition of CXCR4 driven colorectal cancer progression by Nef-M1 peptide Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3879 |
0.32 |
|
| 2019 |
Agarwal S, Chakravarthi BV, Behring M, Kim H, Hale K, Alsubaie AM, Diffalha SA, Sugandha SP, Varambally S, Manne U. Abstract 851: MicroRNA-124 modulated collagen-prolyl hydroxylase P4HA1 expression regulates colon cancer progression Cancer Research. 79: 851-851. DOI: 10.1158/1538-7445.Am2019-851 |
0.487 |
|
| 2019 |
Behring M, Ozaydin B, Manne U. Abstract 4209: Codon 72 polymorphisms of p53 are associated with obesity, diabetes, and race in breast cancer Cancer Research. 79: 4209-4209. DOI: 10.1158/1538-7445.Am2019-4209 |
0.319 |
|
| 2018 |
Behring M, Shrestha S, Manne U, Cui X, Gonzalez-Reymundez A, Grueneberg A, Vazquez AI. Integrated landscape of copy number variation and RNA expression associated with nodal metastasis in invasive ductal breast carcinoma. Oncotarget. 9: 36836-36848. PMID 30627325 DOI: 10.18632/Oncotarget.26386 |
0.342 |
|
| 2018 |
Chakravarthi BVSK, Chandrashekar DS, Hodigere Balasubramanya SA, Robinson AD, Carskadon S, Rao U, Gordetsky J, Manne U, Netto GJ, Sudarshan S, Palanisamy N, Varambally S. Wnt receptor Frizzled 8 is a target of ERG in prostate cancer. The Prostate. PMID 30051493 DOI: 10.1002/Pros.23704 |
0.324 |
|
| 2018 |
Mittal K, Bhattarai S, Klimov S, Krishnamurthi U, Li X, Wetherilt CS, Aleskandaran MA, Green AA, Rakha EA, Ellis IO, Cantuaria G, Wei G, Osan RM, Gupta MV, Manne U, et al. Abstract PR02: β-Catenin overexpression underlies the aggressive disease course in African American triple-negative breast cancer patients who lack androgen receptor Cancer Epidemiology, Biomarkers & Prevention. 27. DOI: 10.1158/1538-7755.Disp17-Pr02 |
0.351 |
|
| 2017 |
Zhang W, Zhang B, Vu T, Yuan G, Zhang B, Chen X, Manne U, Datta PK. Molecular characterization of pro-metastatic functions of β4-integrin in colorectal cancer. Oncotarget. 8: 92333-92345. PMID 29190919 DOI: 10.18632/Oncotarget.21290 |
0.366 |
|
| 2017 |
Chowdhury R, Gales D, Valenzuela P, Miller S, Yehualaeshet T, Manne U, Francia G, Samuel T. Bromoethylindole (BEI-9) redirects NF-κB signaling induced by camptothecin and TNFα to promote cell death in colon cancer cells. Apoptosis : An International Journal On Programmed Cell Death. PMID 29116428 DOI: 10.1007/S10495-017-1427-6 |
0.311 |
|
| 2017 |
Katkoori VR, Manne U, Chaturvedi LS, Basson MD, Haan P, Coffey D, Bumpers HL. Functional consequence of the p53 codon 72 polymorphism in colorectal cancer. Oncotarget. 8: 76574-76586. PMID 29100333 DOI: 10.18632/Oncotarget.20580 |
0.383 |
|
| 2017 |
Chakravarthi BVSK, Chandrashekar DS, Agarwal S, Hodigere Balasubramanya SA, Pathi SS, Goswami MT, Jing X, Wang R, Mehra R, Asangani I, Chinnaiyan AM, Manne U, Sonpavde G, Netto GJ, Gordetsky JB, et al. miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression. Molecular Cancer Research : McR. PMID 29025958 DOI: 10.1158/1541-7786.Mcr-17-0230 |
0.418 |
|
| 2017 |
Jia X, Shanmugam C, Paluri RK, Jhala NC, Behring MP, Katkoori VR, Sugandha SP, Bae S, Samuel T, Manne U. Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer. Oncotarget. 8: 20198-20212. PMID 28423626 DOI: 10.18632/Oncotarget.15560 |
0.385 |
|
| 2017 |
Koo DH, Singh B, Jiang J, Friebe B, Gill BS, Chastain PD, Manne U, Tiwari HK, Singh KK. Single-molecule mtDNA fiber FISH for analyzing numtogenesis. Analytical Biochemistry. PMID 28322800 DOI: 10.1016/J.Ab.2017.03.015 |
0.31 |
|
| 2017 |
Kumar S, Eroglu E, Stokes JA, Scissum-Gunn K, Saldanha SN, Singh UP, Manne U, Ponnazhagan S, Mishra MK. Resveratrol induces mitochondria-mediated, caspase-independent apoptosis in murine prostate cancer cells. Oncotarget. PMID 28157696 DOI: 10.18632/Oncotarget.14947 |
0.301 |
|
| 2017 |
Katkoori VR, Manne U, Bumpers H. Abstract 781: Functional consequence of the p53 codon 72 polymorphism in colorectal cancer Cancer Research. 77: 781-781. DOI: 10.1158/1538-7445.Am2017-781 |
0.376 |
|
| 2016 |
Manne U, Jadhav T, Putcha BK, Samuel T, Soni S, Shanmugam C, Suswam EA. Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective. Current Colorectal Cancer Reports. 12: 332-344. PMID 28626361 DOI: 10.1007/S11888-016-0338-1 |
0.475 |
|
| 2016 |
Govindarajan R, Posey J, Chao CY, Lu R, Jadhav T, Javed AY, Javed A, Mahmoud FA, Osarogiagbon RU, Manne U. A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer. Bmc Cancer. 16: 368. PMID 27316467 DOI: 10.1186/S12885-016-2365-3 |
0.418 |
|
| 2016 |
Krishn SR, Kaur S, Smith LM, Johansson SL, Jain M, Patel A, Gautam SK, Hollingsworth MA, Mandel U, Clausen H, Lo WC, Fan WL, Manne U, Batra SK. Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer. Cancer Letters. PMID 26898938 DOI: 10.1016/J.Canlet.2016.02.016 |
0.404 |
|
| 2016 |
Paluri RK, Behring M, Posey J, Manne U. Effect of age and ethnicity on the tumor location, nuclear accumulation of p53 and clinical outcome in colorectal adenocarcinoma. Journal of Clinical Oncology. 34: 559-559. DOI: 10.1200/Jco.2016.34.4_Suppl.559 |
0.379 |
|
| 2016 |
Kumar S, Stokes J, Gunn KS, Ponnazhagan S, Manne U, Mishra MK. Abstract 4328: Resveratrol inhibits NO-mediated oxidative stress in murine prostate cancer cells Cancer Research. 76: 4328-4328. DOI: 10.1158/1538-7445.Am2016-4328 |
0.301 |
|
| 2016 |
Chowdhury R, Miller SA, Gales D, White J, Manne U, Samuel T. Abstract 3783: Co-treatment of metastasis-derived colon cancer cells with bromoethyl indole (BEI) enhances camptothecin or TNF alpha-induced cell death Cancer Research. 76: 3783-3783. DOI: 10.1158/1538-7445.Am2016-3783 |
0.36 |
|
| 2016 |
Yeh C, Spurgin J, Ford A, Athanasuleas J, Manne U. Abstract 3148: Clinical validation of a next-generation sequencing assay specifically for blood-drop liquid biopsy Cancer Research. 76: 3148-3148. DOI: 10.1158/1538-7445.Am2016-3148 |
0.318 |
|
| 2016 |
Suswam EA, Kumar G, Kim H, Osmar M, Kouni MHe, Manne U. Abstract 2159:In vitrocharacterization of PTAU and FU interactions in colon cancer cells Cancer Research. 76: 2159-2159. DOI: 10.1158/1538-7445.Am2016-2159 |
0.412 |
|
| 2015 |
Narayanan NK, Kunimasa K, Yamori Y, Mori M, Mori H, Nakamura K, Miller G, Manne U, Tiwari AK, Narayanan B. Antitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in a colon-26 tumor-bearing mouse model in vivo. Cancer Medicine. PMID 26408414 DOI: 10.1002/Cam4.520 |
0.336 |
|
| 2015 |
Katkoori VR, Basson MD, Bond VC, Manne U, Bumpers HL. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers. Oncotarget. 6: 27763-77. PMID 26318034 DOI: 10.18632/Oncotarget.4615 |
0.328 |
|
| 2015 |
Putcha BD, Jia X, Katkoori VR, Salih C, Shanmugam C, Jadhav T, Bovell LC, Behring MP, Callens T, Messiaen L, Bae S, Grizzle WE, Singh KP, Manne U. Clinical Implications of Rabphillin-3A-Like Gene Alterations in Breast Cancer. Plos One. 10: e0129216. PMID 26070152 DOI: 10.1371/Journal.Pone.0129216 |
0.77 |
|
| 2015 |
Bumpers HL, Janagama DG, Manne U, Basson MD, Katkoori V. Nanomagnetic levitation three-dimensional cultures of breast and colorectal cancers. The Journal of Surgical Research. 194: 319-26. PMID 25617973 DOI: 10.1016/J.Jss.2014.12.036 |
0.325 |
|
| 2015 |
Karthikeyan C, Lee C, Moore J, Mittal R, Suswam EA, Abbott KL, Pondugula SR, Manne U, Narayanan NK, Trivedi P, Tiwari AK. IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells. Bioorganic & Medicinal Chemistry. 23: 602-11. PMID 25537531 DOI: 10.1016/J.Bmc.2014.11.043 |
0.378 |
|
| 2015 |
Govindarajan R, Posey J, Chao CY, Lu R, Jadhav T, Javed AY, Javed A, Mahmoud FA, Osarogiagbon RU, Manne U. Recurrence score distributions in stage II colon cancers of African American (AA) and Caucasian (CA) patients. Journal of Clinical Oncology. 33: 613-613. DOI: 10.1200/Jco.2015.33.3_Suppl.613 |
0.355 |
|
| 2015 |
Pennison MJ, Zeng Q, Buckhaults PJ, Kaklamani VG, Lindor NM, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA, Haile RW, Baron JA, Stram DO, Zhang H, Manne U, Edberg JC, et al. Dual role of TGFBR1 as a modifier of colorectal cancer risk. Journal of Clinical Oncology. 33: 600-600. DOI: 10.1200/Jco.2015.33.3_Suppl.600 |
0.333 |
|
| 2015 |
Gales DN, Fadlalla K, Manne U, Yates C, Samuel T. Abstract B11: Stromal response to prostate cancer therapeutics Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Pms14-B11 |
0.368 |
|
| 2015 |
Katkoori V, Chaturvedi L, Basson MD, Manne U, Bumpers HL. Abstract 51: The codon 72 polymorphism in p53 is a gain-of-function alteration leading to activation of map kinase signaling and epithelial-to-mesenchymal transition in colon cancer Cancer Research. 75: 51-51. DOI: 10.1158/1538-7445.Am2015-51 |
0.382 |
|
| 2015 |
Suswam EA, Putcha BK, Tiwari AK, Jadhav T, Walker KD, Harkins L, Amer S, Eltoum I, Bae S, Manne U. Abstract 4953: Molecular and cellular localization profiles of tristetraprolin in colorectal cancer: Implications for tumor progression in diverse patient populations Cancer Research. 75: 4953-4953. DOI: 10.1158/1538-7445.Am2015-4953 |
0.376 |
|
| 2015 |
Putcha BK, Jadhav T, Behring MP, Bae S, Frost AR, Eltoum I, Chen L, Weiss HL, Grizzle WE, Manne U. Abstract 4004: Prognostic value of miRNAs in breast cancer varies with patient race and molecular subtype Cancer Research. 75: 4004-4004. DOI: 10.1158/1538-7445.Am2015-4004 |
0.435 |
|
| 2015 |
Jadhav T, Salazar-Gonzalez J, Hebert-Magee S, Behring M, Putcha B, Bae JH, Frost A, Eltoum I, Bae S, Manne U. Abstract 2776: Codon 72 and Intron-3 polymorphisms in TP53 are risk factors for breast cancer Epidemiology. 75: 2776-2776. DOI: 10.1158/1538-7445.Am2015-2776 |
0.301 |
|
| 2014 |
Samuel T, Fadlalla K, Gales DN, Putcha BD, Manne U. Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugs. Bmc Cancer. 14: 599. PMID 25134433 DOI: 10.1186/1471-2407-14-599 |
0.333 |
|
| 2014 |
Paluri RK, Council L, Putcha BK, Jadav T, Manne U, Posey J. The influence of vitamin D and receptor status in colorectal cancer. Journal of Clinical Oncology. 32: 435-435. DOI: 10.1200/Jco.2014.32.3_Suppl.435 |
0.346 |
|
| 2014 |
Putcha BK, Jadhav T, Hebert-Magee S, Bae JH, Frost AR, Eltoum I, Bae S, Manne U. Abstract PR5: Prognostic value of miRNAs in breast cancer: Molecular type and patient race Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-Pr5 |
0.502 |
|
| 2014 |
Suswam EA, Putcha BDK, Walker KD, Johnson L, Howard J, Partridge EE, Fouad MN, Bae S, Manne U. Abstract C77: Tristetraprolin suppression is associated with advanced stage colorectal cancer Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-C77 |
0.405 |
|
| 2014 |
Bumpers HL, Katkoori V, Chen D, Manne U. Abstract C56: The role of BetaB2-crystallin in progression of colorectal and breast cancers in African Americans Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-C56 |
0.457 |
|
| 2014 |
Putcha BK, Holt BM, Bovell L, Jadhav T, Manne U. Abstract C22: Overexpression of miR-181b and underlying molecular mechanisms in aggressive progression of African American colorectal cancers Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-C22 |
0.427 |
|
| 2014 |
Putcha BK, Hebert-Magee S, Jadhav T, Frost AR, Eltoum I, Manne U. Abstract LB-287: Racial disparity in the TP53 mutation spectra in triple-negative breast cancers: Validation with TCGA data Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-287 |
0.321 |
|
| 2014 |
Jadhav T, Narang S, Bae J, Schultz M, Eltoum I, Bellis S, Bae S, Manne U. Abstract 3820: Expression of ST6Gal-1 in colorectal cancer and patient prognosis Cancer Research. 74: 3820-3820. DOI: 10.1158/1538-7445.Am2014-3820 |
0.451 |
|
| 2014 |
Katkoori VR, Basson MD, Manne U, Bumpers HL. Abstract 1027: Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis by attenuating AKT and mitogen-activated protein kinase signaling in colon cancer Cancer Research. 74: 1027-1027. DOI: 10.1158/1538-7445.Am2014-1027 |
0.345 |
|
| 2013 |
Bumpers H, Huang MB, Katkoori V, Manne U, Bond V. Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast Cancer. Journal of Cancer Therapy. 4: 898-906. PMID 25285238 DOI: 10.4236/Jct.2013.44101 |
0.309 |
|
| 2013 |
Gales D, Clark C, Manne U, Samuel T. The Chemokine CXCL8 in Carcinogenesis and Drug Response. Isrn Oncology. 2013: 859154. PMID 24224100 DOI: 10.1155/2013/859154 |
0.31 |
|
| 2013 |
Bovell LC, Shanmugam C, Putcha BD, Katkoori VR, Zhang B, Bae S, Singh KP, Grizzle WE, Manne U. The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 3955-65. PMID 23719259 DOI: 10.1158/1078-0432.Ccr-12-3302 |
0.799 |
|
| 2013 |
Bovell LC, Putcha BD, Samuel T, Manne U. Clinical implications of microRNAs in cancer. Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission. 88: 388-96. PMID 23647010 DOI: 10.3109/10520295.2013.788735 |
0.784 |
|
| 2013 |
Vogtmann E, Shanmugam C, Katkoori VR, Waterbor J, Manne U. Socioeconomic status, p53 abnormalities, and colorectal cancer. Journal of Gastrointestinal Oncology. 4: 40-4. PMID 23450636 DOI: 10.3978/J.Issn.2078-6891.2012.054 |
0.394 |
|
| 2013 |
McNally L, Manne U, Grizzle WE. Post-transcriptional processing of genetic information and its relation to cancer. Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission. 88: 365-72. PMID 23286224 DOI: 10.3109/10520295.2012.730152 |
0.402 |
|
| 2013 |
Katkoori VR, Manne K, Vital-Reyes VS, Rodríguez-Burford C, Shanmugam C, Sthanam M, Manne U, Chatla C, Abdulkadir SA, Grizzle WE. Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53 Biotechnic and Histochemistry. 88: 38-46. PMID 23167625 DOI: 10.3109/10520295.2012.724713 |
0.32 |
|
| 2013 |
Jadhav T, Chen D, Putcha BK, Samuel T, Posey J, Heslin M, Manne U. Abstract 4031: Distinct gene expression profile of recurrent stage II colorectal cancers in African American and Caucasian American patients. Cancer Research. 73: 4031-4031. DOI: 10.1158/1538-7445.Am2013-4031 |
0.372 |
|
| 2013 |
Katkoori VR, Manne U, Basson MD, Bumpers HL. Abstract 2620: Progressive expression of n-cadherin and epidermal growth factor receptor in colorectal adenocarcinoma. Cancer Research. 73: 2620-2620. DOI: 10.1158/1538-7445.Am2013-2620 |
0.389 |
|
| 2013 |
Bovell L, Putcha BK, Devadasan D, Bae S, Grizzle WE, Manne U. Abstract 1944: Evaluation of the prognostic value of miRNA-181b and its target identification and validation in colorectal cancers. Cancer Research. 73: 1944-1944. DOI: 10.1158/1538-7445.Am2013-1944 |
0.792 |
|
| 2013 |
Samuel T, Fadlalla K, Elgendy R, Putcha BK, Posey J, Manne U. Abstract B70: Differential activation of NF-kB signaling and CXCL8 secretion in colon cancer cells treated with chemotherapeutic drugs. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-B70 |
0.33 |
|
| 2012 |
Tuupanen S, Yan J, Turunen M, Gylfe AE, Kaasinen E, Li L, Eng C, Culver DA, Kalady MF, Pennison MJ, Pasche B, Manne U, de la Chapelle A, Hampel H, Henderson BE, et al. Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583. Cancer Genetics. 205: 25-33. PMID 22429595 DOI: 10.1016/J.Cancergen.2012.01.005 |
0.351 |
|
| 2012 |
Katkoori VR, Shanmugam C, Jia X, Vitta SP, Sthanam M, Callens T, Messiaen L, Chen D, Zhang B, Bumpers HL, Samuel T, Manne U. Prognostic significance and gene expression profiles of p53 mutations in microsatellite-stable stage III colorectal adenocarcinomas. Plos One. 7: e30020. PMID 22276141 DOI: 10.1371/Journal.Pone.0030020 |
0.373 |
|
| 2012 |
Bovell L, Shanmugam C, Katkoori VR, Zhang B, Vogtmann E, Grizzle WE, Manne U. miRNAs are stable in colorectal cancer archival tissue blocks. Frontiers in Bioscience (Elite Edition). 4: 1937-40. PMID 22202009 DOI: 10.2741/514 |
0.791 |
|
| 2012 |
Samuel T, Fadlalla K, Katkoori V, Khazal K, Turner T, Manne U. Abstract 4664: Co-treatment of cancer cells with DNA damaging drugs and quercetin suppresses cell growth independent of p21 and Bax induction Cancer Research. 72: 4664-4664. DOI: 10.1158/1538-7445.Am2012-4664 |
0.35 |
|
| 2012 |
Katkoori VR, Choudhary S, Butler AR, Shanmugam C, Bovell LL, Samuel T, Athar M, Grizzle WE, Manne U. Abstract 4156: Interaction between therabphillin-3A-likegene and phosphorylation of mammalian target of rapamycin (mTOR) in colorectal cancer Cancer Research. 72: 4156-4156. DOI: 10.1158/1538-7445.Am2012-4156 |
0.425 |
|
| 2012 |
Shanmugam C, Katkoori VR, Sthanam M, Hanna A, Manne U. Abstract 1158: Clinical significance of p53 codon 72 polymorphism in hepatocellular carcinomas Cancer Research. 72: 1158-1158. DOI: 10.1158/1538-7445.Am2012-1158 |
0.332 |
|
| 2012 |
Katkoori VR, Shanmugam C, Sthanam M, Callens T, Messiaen LM, Bumpers HL, Manne U, Birdsong GG, Samuel T. Abstract 1152: Clinical relevance of elevated microsatellite alterations at selected tetranucleotide repeats in colorectal adenocarcinomas Cancer Research. 72: 1152-1152. DOI: 10.1158/1538-7445.Am2012-1152 |
0.412 |
|
| 2011 |
Kennedy RD, Bylesjo M, Kerr P, Davison T, Black JM, Kay EW, Holt RJ, Proutski V, Ahdesmaki M, Farztdinov V, Goffard N, Hey P, McDyer F, Mulligan K, Mussen J, ... ... Manne U, et al. Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4620-6. PMID 22067406 DOI: 10.1200/Jco.2011.35.4498 |
0.378 |
|
| 2011 |
Bumpers HL, Goud JD, DeBeatham WL, Manne U. Abstract 4298: Nanomagnetic levitation based 3-D cultures of breast and colon cancer cells for high throughput drug screening and xenograft studies Cancer Research. 71: 4298-4298. DOI: 10.1158/1538-7445.Am2011-4298 |
0.317 |
|
| 2011 |
Shanmugam C, Salih C, Katkoori VR, Bovell LL, Callens T, Messiaen LM, Hameed O, Grizzle WE, Manne U. Abstract 2271: Single nucleotide polymorphisms inp53codon 72 is associated with grade III tumors in African Americans with breast carcinoma Cancer Research. 71: 2271-2271. DOI: 10.1158/1538-7445.Am2011-2271 |
0.356 |
|
| 2011 |
Ahluwalia S, Shanmugam C, Katkoori VR, Jhala NC, Sugandha SP, Grizzle WE, Manne U. Abstract 2262: The prognostic value of p53 abnormalities in colorectal cancers varies based on detection methods Cancer Research. 71: 2262-2262. DOI: 10.1158/1538-7445.Am2011-2262 |
0.379 |
|
| 2011 |
Katkoori VR, Salih C, Sthanam M, Shanmugam C, Callens T, Messiaen LM, Grizzle WE, Bumpers HL, Birdsong G, Manne U. Abstract 2261: Prognostic significance of the low level microsatellite instability phenotype differs with race in colorectal adenocarcinoma Cancer Research. 71: 2261-2261. DOI: 10.1158/1538-7445.Am2011-2261 |
0.364 |
|
| 2011 |
Vogtmann E, Shanmugam C, Katkoori V, Waterbor J, Manne U. Abstract 1923: Association between socioeconomic status and p53 abnormalities among colorectal cancer patients Cancer Research. 71: 1923-1923. DOI: 10.1158/1538-7445.Am2011-1923 |
0.383 |
|
| 2011 |
Bovell LC, Shanmugam C, Katkoori V, Salih C, Grizzle WE, Manne U. Abstract 1167: Fixation does not affect the integrity of microRNAs in archival colorectal cancer specimens over a period of 20 years Cancer Research. 71: 1167-1167. DOI: 10.1158/1538-7445.Am2011-1167 |
0.797 |
|
| 2010 |
Katkoori VR, Suarez-Cuervo C, Shanmugam C, Jhala NC, Callens T, Messiaen L, Posey J, Bumpers HL, Meleth S, Grizzle WE, Manne U. Bax expression is a candidate prognostic and predictive marker of colorectal cancer. Journal of Gastrointestinal Oncology. 1: 76-89. PMID 22811811 DOI: 10.3978/J.Issn.2078-6891.2010.019 |
0.394 |
|
| 2010 |
Manne U, Shanmugam C, Katkoori VR, Bumpers HL, Grizzle WE. Development and progression of colorectal neoplasia. Cancer Biomarkers : Section a of Disease Markers. 9: 235-65. PMID 22112479 DOI: 10.3233/Cbm-2011-0160 |
0.387 |
|
| 2010 |
Grizzle WE, Srivastava S, Manne U. Translational pathology of neoplasia. Cancer Biomarkers : Section a of Disease Markers. 9: 7-20. PMID 22112467 DOI: 10.3233/Cbm-2011-0159 |
0.359 |
|
| 2010 |
Manne U, Shanmugam C, Bovell L, Katkoori VR, Bumpers HL. miRNAs as biomarkers for management of patients with colorectal cancer. Biomarkers in Medicine. 4: 761-70. PMID 20945991 DOI: 10.2217/Bmm.10.87 |
0.794 |
|
| 2010 |
Shanmugam C, Jhala NC, Katkoori VR, Wan W, Meleth S, Grizzle WE, Manne U. Prognostic value of mucin 4 expression in colorectal adenocarcinomas. Cancer. 116: 3577-86. PMID 20564074 DOI: 10.1002/Cncr.25095 |
0.37 |
|
| 2010 |
Anderson B, Hardin JM, Alexander DD, Grizzle WE, Meleth S, Manne U. Comparison of the predictive qualities of three prognostic models of colorectal cancer. Frontiers in Bioscience (Elite Edition). 2: 849-56. PMID 20515758 DOI: 10.2741/E146 |
0.302 |
|
| 2010 |
Papageorgis P, Lambert AW, Ozturk S, Gao F, Pan H, Manne U, Alekseyev YO, Thiagalingam A, Abdolmaleky HM, Lenburg M, Thiagalingam S. Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Research. 70: 968-78. PMID 20086175 DOI: 10.1158/0008-5472.Can-09-1872 |
0.307 |
|
| 2010 |
Shah HR, Morgan D, Manne U, Jhala N, Cantor A, Posey J. Early imaging and molecular response determinants in advanced pancreatic cancer. Journal of Clinical Oncology. 28: e14636-e14636. DOI: 10.1200/Jco.2010.28.15_Suppl.E14636 |
0.339 |
|
| 2010 |
Vogtmann EJ, Shanmugam C, Waterbor J, Bumpers H, Manne U. Abstract LB-418: Factors associated with colorectal cancer survival vary by gender Epidemiology. 70. DOI: 10.1158/1538-7445.Am10-Lb-418 |
0.379 |
|
| 2010 |
Shanmugam C, Hines RB, Jhala NC, Bumpers HL, Posey JA, Birdsong G, Manne U. Abstract 846: Clinical relevance of lymph node evaluation in Stage II and III colon cancers Cancer Research. 70: 846-846. DOI: 10.1158/1538-7445.Am10-846 |
0.304 |
|
| 2010 |
Katkoori VR, Shanmugam CK, Chen D, Bumper HL, Collens T, Messiaen L, Manne U. Abstract 4655: Gene expression signatures of microsatellite-stable stage III colorectal adenocarcinomas based on thep53status Cancer Research. 70: 4655-4655. DOI: 10.1158/1538-7445.Am10-4655 |
0.405 |
|
| 2010 |
Salih C, Jia X, Shanmugam C, Katkoori VR, Callens T, Messiaen LM, Hameed O, Manne U. Abstract 4647: Clinical Implications of Rabphillin-3A-Like (RPH3AL/NOC2) Gene Alterations in Breast Cancer Cancer Research. 70: 4647-4647. DOI: 10.1158/1538-7445.Am10-4647 |
0.363 |
|
| 2010 |
Bovell L, Katkoori VR, Shanmugam C, Lee CH, Meleth S, Bumpers HL, Grizzle WE, Manne U. Abstract 4037: Higher Expressions of miR-21, miR-106a, miR-181b, and miR-203 are Associated with Poor Prognosis in Colorectal Cancer Patients Cancer Research. 70: 4037-4037. DOI: 10.1158/1538-7445.Am10-4037 |
0.786 |
|
| 2009 |
Posey JA, Koya S, Katkoori VR, Davis DE, Manne U. Prognostic significance of VDR, DKK-1, and DKK-4 expression in colorectal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e15047. PMID 27964440 DOI: 10.1200/Jco.2009.27.15_Suppl.E15047 |
0.39 |
|
| 2009 |
Andea AA, Patel R, Ponnazhagan S, Kumar S, DeVilliers P, Jhala D, Eltoum I, Manne U, Siegal G. Detection of Merkel cell polyomavirus in formalin-fixed, paraffin-embedded tissue of Merkel cell carcinoma and its correlation with prognosis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6027. PMID 27962435 DOI: 10.1200/Jco.2009.27.15_Suppl.6027 |
0.305 |
|
| 2009 |
Harrington W, Bond V, Huang MB, Powell M, Lillard J, Manne U, Bumpers H. HIV Nef-M1 Effects on Colorectal Cancer Growth in Tumor-induced Spleens and Hepatic Metastasis. Molecular and Cellular Pharmacology. 1: 85-91. PMID 20383296 DOI: 10.4255/Mcpharmacol.09.10 |
0.331 |
|
| 2009 |
Hines RB, Shanmugam C, Waterbor JW, McGwin G, Funkhouser E, Coffey CS, Posey J, Manne U. Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer. Cancer. 115: 5798-806. PMID 19937953 DOI: 10.1002/Cncr.24598 |
0.322 |
|
| 2009 |
Hines RB, Chatla C, Bumpers HL, Waterbor JW, McGwin G, Funkhouser E, Coffey CS, Posey J, Manne U. Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 4339-45. PMID 19652054 DOI: 10.1200/Jco.2009.22.4758 |
0.363 |
|
| 2009 |
Katkoori VR, Jia X, Shanmugam C, Wan W, Meleth S, Bumpers H, Grizzle WE, Manne U. Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2406-16. PMID 19339276 DOI: 10.1158/1078-0432.Ccr-08-1719 |
0.361 |
|
| 2009 |
Shanmugam C, Katkoori VR, Jhala NC, Grizzle WE, Manne U. Immunohistochemical expression of rabphilin-3A-like (Noc2) in normal and tumor tissues of human endocrine pancreas. Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission. 84: 39-45. PMID 19212825 DOI: 10.1080/10520290902738878 |
0.31 |
|
| 2008 |
Matthews KS, Estes JM, Conner MG, Manne U, Whitworth JM, Huh WK, Alvarez RD, Straughn JM, Barnes MN, Rocconi RP. Lynch syndrome in women less than 50 years of age with endometrial cancer. Obstetrics and Gynecology. 111: 1161-6. PMID 18448750 DOI: 10.1097/Aog.0B013E31817051D9 |
0.33 |
|
| 2008 |
Shanmugam C, Katkoori VR, Jhala NC, Grizzle WE, Siegal GP, Manne U. p53 Nuclear accumulation and Bcl-2 expression in contiguous adenomatous components of colorectal adenocarcinomas predict aggressive tumor behavior. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 56: 305-12. PMID 18071066 DOI: 10.1369/Jhc.7A7362.2007 |
0.384 |
|
| 2008 |
Katkoori VR, Jia X, Chatla C, Kumar S, Ponnazhagan S, Callens T, Messiaen L, Grizzle WE, Manne U. Clinical significance of a novel single nucleotide polymorphism in the 5' untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma. Frontiers in Bioscience : a Journal and Virtual Library. 13: 1050-61. PMID 17981610 DOI: 10.2741/2742 |
0.354 |
|
| 2007 |
Meleth S, Chatla C, Katkoori VR, Anderson B, Hardin JM, Jhala NC, Bartolucci A, Grizzle WE, Manne U. Comparison of predicted probabilities of proportional hazards regression and linear discriminant analysis methods using a colorectal cancer molecular biomarker database. Cancer Informatics. 3: 115-22. PMID 19455238 DOI: 10.4137/Cin.S0 |
0.324 |
|
| 2007 |
Alexander DD, Waterbor J, Hughes T, Funkhouser E, Grizzle W, Manne U. African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review. Cancer Biomarkers : Section a of Disease Markers. 3: 301-13. PMID 18048968 DOI: 10.3233/Cbm-2007-3604 |
0.353 |
|
| 2007 |
Manne U. Understanding racial differences in colorectal cancer aids in individualized medicine. Future Oncology (London, England). 3: 235-41. PMID 17547516 DOI: 10.2217/14796694.3.3.235 |
0.322 |
|
| 2006 |
Verma M, Manne U. Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations. Critical Reviews in Oncology/Hematology. 60: 9-18. PMID 16829121 DOI: 10.1016/J.Critrevonc.2006.04.002 |
0.358 |
|
| 2006 |
Manne U, Suarez-Cuervo C, Jhala NC, Posey J, Herring CB, Meleth S, Grizzle WE. Phenotypic expression of Bax is a predictive marker of 5-fluorouracil treatment in colorectal cancer Journal of Clinical Oncology. 24: 3605-3605. DOI: 10.1200/Jco.2006.24.18_Suppl.3605 |
0.407 |
|
| 2005 |
Chatla C, Jhala NC, Katkoori VR, Alexander D, Meleth S, Grizzle WE, Manne U. Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma. Cancer Biomarkers : Section a of Disease Markers. 1: 241-50. PMID 17192048 DOI: 10.3233/Cbm-2005-14-507 |
0.391 |
|
| 2005 |
Manne U, Srivastava RG, Srivastava S. Recent advances in biomarkers for cancer diagnosis and treatment. Drug Discovery Today. 10: 965-76. PMID 16023055 DOI: 10.1016/S1359-6446(05)03487-2 |
0.308 |
|
| 2005 |
Alexander D, Jhala N, Chatla C, Steinhauer J, Funkhouser E, Coffey CS, Grizzle WE, Manne U. High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas. Cancer. 103: 2163-70. PMID 15816050 DOI: 10.1002/Cncr.21021 |
0.312 |
|
| 2004 |
Alexander D, Chatla C, Funkhouser E, Meleth S, Grizzle WE, Manne U. Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma. Cancer. 101: 66-76. PMID 15221990 DOI: 10.1002/Cncr.20337 |
0.339 |
|
| 2004 |
Manne U, Jhala NC, Jones J, Weiss HL, Chatla C, Meleth S, Suarez-Cuervo C, Grizzle WE. Prognostic significance of p27(kip-1) expression in colorectal adenocarcinomas is associated with tumor stage. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 1743-52. PMID 15014027 DOI: 10.1158/1078-0432.Ccr-03-0037 |
0.364 |
|
| 2004 |
Alexander D, Chatla C, Funkhouser E, Jhala N, Grizzle W, Manne U. Racial differences in survival based on tumor differentiation and stage in patients who have undergone surgery for colon cancer Journal of Clinical Oncology. 22: 3609-3609. DOI: 10.1200/Jco.2004.22.90140.3609 |
0.363 |
|
| 2003 |
Piyathilake CJ, Frost AR, Manne U, Weiss H, Heimburger DC, Grizzle WE. Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers. Chest. 123: 181-6. PMID 12527620 DOI: 10.1378/Chest.123.1.181 |
0.342 |
|
| 2003 |
Drake RR, Manne U, Adam B, Ahn C, Cazares L, Semmes O, Bigbee WL, Grizzle WE, Johnson DA. SELDI-TOF-MS profiling of serum for early detection of colorectal cancer Gastroenterology. 124: A650. DOI: 10.1016/S0016-5085(03)83293-6 |
0.331 |
|
| 2002 |
Grizzle WE, Manne U, Weiss HL, Jhala N, Talley L. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1). International Journal of Cancer. Journal International Du Cancer. 97: 403-9. PMID 11802199 DOI: 10.1002/Ijc.1617 |
0.393 |
|
| 2000 |
Manne U, Weiss HL, Grizzle WE. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 6: 4017-25. PMID 11051251 |
0.306 |
|
| 2000 |
Piyathilake CJ, Frost AR, Manne U, Bell WC, Weiss H, Heimburger DC, Grizzle WE. The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Human Pathology. 31: 1068-73. PMID 11014573 DOI: 10.1053/Hupa.2000.9842 |
0.352 |
|
| 2000 |
Manne U, Weiss HL, Grizzle WE. Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas. International Journal of Cancer. 89: 423-30. PMID 11008204 DOI: 10.1002/1097-0215(20000920)89:5<423::Aid-Ijc5>3.0.Co;2-T |
0.42 |
|
| 2000 |
Piyathilake CJ, Frost AR, Weiss H, Manne U, Heimburger DC, Grizzle WE. The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung Human Pathology. 31: 482-487. PMID 10821496 DOI: 10.1053/Hp.2000.6711 |
0.392 |
|
| 1999 |
Urban D, Myers R, Manne U, Weiss H, Mohler J, Perkins D, Markiewicz M, Lieberman R, Kelloff G, Marshall M, Grizzle W. Evaluation of biomarker modulation by fenretinide in prostate cancer patients European Urology. 35: 429-438. PMID 10325501 DOI: 10.1159/000019875 |
0.343 |
|
| 1998 |
Manne U, Weiss HL, Myers RB, Danner OK, Moron C, Srivastava S, Grizzle WE. Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor. Cancer. 83: 2456-67. PMID 9874449 DOI: 10.1002/(Sici)1097-0142(19981215)83:12<2456::Aid-Cncr8>3.0.Co;2-5 |
0.338 |
|
| 1997 |
Manne U, Myers RB, Moron C, Poczatek RB, Dillard S, Weiss H, Brown D, Srivastava S, Grizzle WE. Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. International Journal of Cancer. 74: 346-58. PMID 9221816 DOI: 10.1002/(Sici)1097-0215(19970620)74:3<346::Aid-Ijc19>3.0.Co;2-9 |
0.381 |
|
| 1997 |
Manne U, Myers RB, Srivastava S, Grizzle WE. Re: loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. Journal of the National Cancer Institute. 89: 585-6. PMID 9106651 DOI: 10.1093/Jnci/89.8.585 |
0.326 |
|
| Show low-probability matches. |